tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yigal Nochomovitz, 102 are a HOLD (15.2%), 551 are a BUY (82.12%), 18 are a SELL (2.68%).
Analyst Yigal Nochomovitz, currently employed at CITI, carries an average stock price target met ratio of 44.81% that have a potential upside of 56.99% achieved within 251 days.
Yigal Nochomovitz’s has documented 1,290 price targets and ratings displayed on 72 stocks. The coverage is on Healthcare, Industrials, Consumer Cyclical sectors.
Most recent stock forecast was given on ZYME, Zymeworks Common Stock.
Analyst best performing recommendations are on ATRA (ATARA BIOTHERAPEUTICS).
The best stock recommendation documented was for LXRX (LEXICON PHARMACEUTICALS) at 3/16/2020. The price target of $2.3 was fulfilled within 1 day with a profit of $0.25 (12.2%) receiving and performance score of 121.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Dec-2019
$13
4 years 1 months 2 days ago
(29-Aug-2022)
1/6 (16.67%)
$4.7 (56.63%)
176
Buy Since 07-Nov-2019
$20
4 years 1 months 7 days ago
(24-Aug-2022)
0/5 (0%)
$14.21 (245.42%)
Buy Since 09-Jan-2020
$29
4 years 1 months 7 days ago
(24-Aug-2022)
0/2 (0%)
$14.55 (100.69%)
Hold Since 23-Aug-2022
$15.25
$27
4 years 1 months 8 days ago
(23-Aug-2022)
9/13 (69.23%)
$0.09 (0.59%)
174
Buy Since 17-Sep-2015
$14
4 years 1 months 8 days ago
(23-Aug-2022)
7/19 (36.84%)
$7.75 (124.00%)
211
Which stock is Yigal Nochomovitz most bullish on?
Which stock is Yigal Nochomovitz most reserved on?
What Year was the first public recommendation made by Yigal Nochomovitz?
